Article Details

Pfizer ships out two cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO

Retrieved on: 2021-03-18 15:33:45

Tags for this article:

Click the tags to see associated articles and topics

Pfizer ships out two cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO. View article details on hiswai:

Excerpt

In the new deal, financials of which were not made public, Pfizer will out-license two ADC candidates, to be known as PYX-201 and PYX-203, while ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up